Research output per year
Research output per year
Personal profile
Headline
ASSOCIATE PROFESSOR Medicine, Clinical Immunology
Fingerprint
Dive into the research topics where Paula Busse is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Asthma beliefs and overuse of short-acting beta-adrenergic receptor agonists among older adults
Ishisaka, Y., Ankam, J., Feldman, J., Busse, P., Wisnivesky, J. P. & Federman, A. D., 2025, In: Journal of Asthma. 62, 2, p. 354-361 8 p.Research output: Contribution to journal › Article › peer-review
-
On-demand treatment of hereditary angioedema attacks: Patient-reported utilization, barriers, and outcomes
Christiansen, S., O'Connor, M., Craig, T., Radojicic, C., Wedner, H. J., Danese, S., Ulloa, J., Desai, V., Utter, C., Andriotti, T., Audhya, P. & Busse, P., 2025, (Accepted/In press) In: Annals of Allergy, Asthma and Immunology.Research output: Contribution to journal › Article › peer-review
Open Access -
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
Petersen, R. S., Fijen, L. M., Apfelbacher, C., Magerl, M., Weller, K., Aberer, W., Adatia, A., Audhya, P., Bara, N. A., Betschel, S., Boccon-Gibod, I., Bouillet, L., Brodszki, N., Busse, P. J., Buttgereit, T., Bygum, A., Cancian, M., Craig, T., Csuka, D. & Farkas, H. & 25 others, , Jun 2024, In: Journal of Allergy and Clinical Immunology: In Practice. 12, 6, p. 1614-1621 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy
Inner-City Asthma and Childhood Asthma in Urban Settings Consortia, Sep 2024, In: Journal of Allergy and Clinical Immunology. 154, 3, p. 735-744.e10Research output: Contribution to journal › Article › peer-review
-
Asthma morbidity measures across Black ethnic subgroups
Ishmael, L., Apter, A., Busse, P. J., Calderon-Candelario, R., Carroll, J. K., Casale, T., Celedón, J. C., Cohen, R., Coyne-Beasley, T., Cui, J., Ericson, B., Hernandez, P., Kaelber, D. C., Maher, N., Merriman, C., Mosnaim, G., Nazario, S., Phipatanakul, W., Pinto-Plata, V. & Riley, I. & 5 others, , Feb 2024, In: Journal of Allergy and Clinical Immunology. 153, 2, p. 408-417 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Press/Media
-
Weekly: Kalvista Pharmaceuticals (KALV: $12.60) keeps rising: up 61% in 9 weeks; +68c [5.7%]
15/03/25
1 item of Media coverage
Press/Media
-
Kalvista Pharmaceuticals continues uptrend, surges 45% and in top 3% of the market
14/03/25
1 item of Media coverage
Press/Media
-
Weekly: Kalvista Pharmaceuticals (KALV: $11.92) keeps rising: up 52% in 8 weeks; +52.5c [4.6%] Vol Index 1.7 [1 is avg]
8/03/25
1 item of Media coverage
Press/Media
-
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
4/03/25
1 item of Media coverage
Press/Media
-
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
3/03/25
11 items of Media coverage
Press/Media